← Back to all reports

AU · COR · F3721

Pharmaceuticals Wholesaling in Australia

Published 2025-12-05

Data Source

IBISWorld API

💡 This data is served live via the IBISWorld API — embed it in your CRM, portal, or internal tool with a few lines of code.

Key Metrics · 2026

Revenue

$26,131.2M

5yr hist.
▲ 3.0%
5yr fcast
▲ 2.2%

IVA

$3,563.6M

5yr hist.
▲ 3.2%
5yr fcast
▲ 2.5%

Employment

13,125

5yr hist.
▲ 0.4%
5yr fcast
▲ 0.6%

Wages

$1,701.9M

5yr hist.
▼ 0.2%
5yr fcast
▲ 1.4%

Profit

$1,567.9M

5yr hist.
▲ 7.3%
5yr fcast
n/a

Profit Margin

6.0%

5yr hist.
▲ 1.1%
5yr fcast
n/a

Executive Summary

5-Year Outlook

Forecast

Revenue Trend

Cost Structure

All Highlights

Metric Value Hist.
Depreciation / Wages 0.2 ▲ 5.2%
IVA / Revenue 13.6% ▲ 0.1%
Revenue per Employee $1,990,949 ▲ 2.6%
Wages/ Revenue 6.5% ▼ 1.1%
Employees per Establishment 7 ▲ 1.1%
Average Wage $129,669 ▼ 0.6%
Revenue per Enterprise $17.8M ▲ 3.7%
Employees per Enterprise 9 ▲ 1.1%
Establishments per Enterprise 1 —
Revenue $26,131.2M ▲ 3.0%
IVA $3,563.6M ▲ 3.2%
Establishments 1,833 ▼ 0.7%
Enterprises 1,469 ▼ 0.7%
Employment 13,125 ▲ 0.4%
Wages $1,701.9M ▼ 0.2%
Profit per Enterprise $1,067,306 ▲ 8.0%
Profit $1,567.9M ▲ 7.3%
Profit Margin 6.0% ▲ 1.1%
Debt / Net Worth 0.3 n/a
Trade Receivables (%) 16.9 n/a
Cash Flow Coverage Ratio 1.8 n/a